Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention

Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention

Background: Controversy still exists that whether clopidogrel should add proton pump inhibitors (PPIs) in patients with coronary heart disease after percutaneous coronary intervention (PCI). The aim of this study was to evaluate the efficacy and safety of clopidogrel added proton pump inhibitors (PP...

Full description

Bibliographic Details
Main Authors: Jun Pang, Qiang Wu, Zheng Zhang, Tong-zhang Zheng, Qiuling Xiang, Ping Zhang, Xiaoqiao Liu, Changhai Zhang, Hongwen Tan, Jing Huang, Wei Liu, Fang Song, Zongzhuang Li, Feng Yue, Zhi Jiang, Fang Wei, Kai Zhou, Feng Tang, Yongyao Yang, Xiangshu Long, Chunyan Kuang, Yueting Wu, Baolin Chen, Ye Tian
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:International Journal of Cardiology: Heart & Vasculature
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906718301866

Internet

http://www.sciencedirect.com/science/article/pii/S2352906718301866

Similar Items